These mechanisms include small RNAs and chromatin- or DNA-modifying protein complexes.
RNAi is a post-transcriptional gene silencing mechanism mediated by small double-stranded RNA (dsRNA) molecules, including small interfering RNAs (siRNAs) and microRNAs (miRNAs) [ 2- 6].
The rapid effects on erythropoiesis, including small increases in reticulocyte counts, support the purported mechanism of action of ACE-536 on late-stage differentiation.
Evidences from many plant species show that sex determination in plants are also regulated by epigenetic mechanisms including that of small noncoding RNAs [ 33].
This heterochromatin is generated by partially redundant mechanisms, including the production of small interfering RNAs (siRNAs) that are incorporated into the RITS protein complex (RNAi-Induced Transcriptional Silencing).
Thus, cells also possess a range of mechanisms to neutralize the free radicals, including small-molecule antioxidants, such as glutathione and vitamin E, and antioxidant enzymes such as superoxide dismutase, glutathione peroxidase and catalase.
However, the underlying mechanisms, including the role of the small intestine, are unclear.
The absence of conserved cytosine methylation patterns in these organisms was instrumental for the identification and characterization of other epigenetic mechanisms, including covalent histone modifications and small noncoding RNAs [ 25– 27].
The use of potent therapies inhibiting critical oncogenic pathways active in epithelial cancers has led to multiple resistance mechanisms, including the development of highly aggressive, small cell neuroendocrine carcinoma (SCNC).
As our understanding of epigenetic mechanisms including DNA methylation, histone modifications, and small noncoding RNAs grows, this area is likely to play a major role in clarifying disease causation and treatment.
